in patients with rectal cancer (RC) and the added value of dual time point PET/CT. Methods Patients (n = 50, 41 males, mean age 52 ± 11 years). All patients underwent resection ± chemotherapy and/or ...

4.8%) but this was not statistically significant (p=0.36). Average time from scan to diagnosis was 512.9 days (1.4 years). Most CT studies (33 of 42, 79%) were after administration of oral contrast.

Objectives To assess diagnostic accuracy of (18)F-fluorodeoxyglucose (FDG) PET/CT (PET) in detection of local recurrence (LR) in patients with rectal cancer (RC), previously surgically treated.

Endoscopic biopsy confirmed adenocarcinoma, with no distant metastases on CT, consistent with Stage III rectal cancer. She initially underwent 5 weeks of long course neoadjuvant chemoradiotherapy ...

Patients must have a colonoscopy and a biopsy-proven diagnosis of rectal cancer. Patients must have a recent CT scan of the chest, abdomen and pelvis. A rectal cancer protocol MRI is recommended prior ...